Dichloromethane (DCM), also known as methylene chloride, is a widely used industrial solvent with applications in paint stripping, degreasing, and pharmaceutical manufacturing.
While its volatility and effectiveness make it valuable in various industries, DCM exposure poses significant health risks, including neurological, respiratory, and carcinogenic effects, particularly in occupational settings.
Dichloromethane (DCM), also known as methylene chloride, is a volatile, colorless liquid with a sweet, chloroform-like odor. It is widely used as an industrial solvent, paint stripper, degreaser, and in the manufacturing of pharmaceuticals, adhesives, and food products.
It was used to decaffeinate coffee, but this has stopped chiefly due to concern about DCM persistence in the final product.
Despite its industrial utility, DCM poses significant health risks, primarily through inhalation and dermal exposure.
DCM is metabolized via two pathways: a cytochrome P450-mediated oxidative pathway and a glutathione conjugation pathway. The oxidative pathway, catalyzed by CYP2E1, produces carbon monoxide as a byproduct, which can lead to elevated carboxyhemoglobin levels in the blood.
Key properties of dichloromethane include:
Chemical Formula: CH₂Cl₂
Molecular Weight: 84.93 g/mol
Boiling Point: 40°C (104°F)
Solubility: Slightly soluble in water, highly miscible with organic solvents
Routes of Exposure: Inhalation, dermal absorption, ingestion (rare)
Toxicological effects of dichloromethane may vary depending on whether a person’s exposure is acute or chronic.
Short-term exposure to high levels of dichloromethane can cause immediate health effects, primarily affecting the nervous, respiratory, and cardiovascular systems. Symptoms may vary depending on the concentration and duration of exposure.
Acute DCM exposure can have the following neurological effects:
Acute DCM exposure can have the following respiratory and cardiovascular effects:
Acute DCM exposure can have the following gastrointestinal effects:
Acute DCM exposure can have the following effects on skin and eyes:
Long-term exposure to lower levels of dichloromethane, particularly in occupational settings, is associated with serious systemic health risks, including organ toxicity and carcinogenicity.
Chronic DCM exposure can have the following neurological effects:
Chronic DCM exposure can have the following hepatic and renal effects:
Chronic DCM exposure has been linked to carcinogenicity:
Chronic exposure to DCM can have the following cardiovascular effects:
Given its toxicity, stringent safety measures are essential when handling dichloromethane:
Ventilation: Proper exhaust and air filtration systems
Personal Protective Equipment (PPE): Respirators, gloves, and protective eyewear
The following groups of people may consider testing for dichloromethane:
Individuals working in industries that use dichloromethane are at the highest risk and should be monitored for exposure. These industries include:
Testing may be considered for patients presenting with symptoms linked to dichloromethane toxicity, especially if they may have recently been exposed to dichloromethane.
Testing for dichloromethane exposure involves measuring the chemical in exhaled air or blood, but these tests only detect recent exposure within a few days. Carboxyhemoglobin levels in blood and formic acid in urine can also be assessed, though they are not specific to dichloromethane.
These tests are not routinely available in standard medical offices and are primarily used in occupational or environmental health assessments.
Elevated levels of dichloromethane or its metabolites (e.g., carbon monoxide) indicate recent or significant exposure. The severity of symptoms often aligns with exposure levels.
Dichloromethane metabolism produces carbon monoxide, contributing to its toxicity. Blood carboxyhemoglobin (COHb) levels can serve as an indirect indicator of exposure.
Low or undetectable levels suggest minimal exposure to DCM or that significant exposure occurred some time ago.
Trace amounts may be present due to widespread industrial use, but this does not necessarily rule out long-term risks. Chronic health effects of low-level exposure remain under investigation.
A thorough occupational and environmental history is key to guiding further evaluation for patients with suspected exposure.
Click here to compare testing options and order testing to assess toxin levels.
CDC - Immediately Dangerous to Life or Health Concentrations (IDLH): Methylene chloride - NIOSH Publications and Products. (2018, November 2). Www.cdc.gov. https://www.cdc.gov/niosh/idlh/75092.html
FACT SHEET 2024 Final Risk Management Rule for Methylene Chloride under TSCA. (2024). https://www.epa.gov/system/files/documents/2024-07/mecl-fact-sheet_0.pdf
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 71.) Dichloromethane. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499382/
Methylene Chloride (Dichloromethane). (n.d.). https://www.epa.gov/sites/default/files/2016-09/documents/methylene-chloride.pdf
Methylene Chloride | ToxFAQsTM | ATSDR. (n.d.). Wwwn.cdc.gov. https://wwwn.cdc.gov/TSP/ToxFAQs/ToxFAQsDetails.aspx?faqid=233&toxid=42
Schlosser PM, Bale AS, Gibbons CF, Wilkins A, Cooper GS. Human health effects of dichloromethane: key findings and scientific issues. Environ Health Perspect. 2015 Feb;123(2):114-9. doi: 10.1289/ehp.1308030. Epub 2014 Oct 17. PMID: 25325283; PMCID: PMC4314245.
SYSTEMATIC EVIDENCE MAP (SEM) FOR METHYLENE CHLORIDE. (2022). https://www.atsdr.cdc.gov/ToxProfiles/SEM-for-Methylene-chloride.pdf
US EPA. (2016, January 15). Risk Management for Methylene Chloride. Www.epa.gov. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-methylene-chloride